APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 188 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,668 | -72.2% | 149 | -33.5% | 0.00% | -50.0% |
| Q2 2023 | $20,406 | +12.1% | 224 | -18.8% | 0.00% | 0.0% |
| Q1 2023 | $18,205 | +24.8% | 276 | -2.1% | 0.00% | 0.0% |
| Q4 2022 | $14,582 | -27.1% | 282 | -5.4% | 0.00% | -33.3% |
| Q3 2022 | $20,000 | +300.0% | 298 | +195.0% | 0.00% | +200.0% |
| Q2 2022 | $5,000 | 0.0% | 101 | +8.6% | 0.00% | 0.0% |
| Q1 2022 | $5,000 | +150.0% | 93 | +144.7% | 0.00% | – |
| Q4 2021 | $2,000 | +100.0% | 38 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 38 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 38 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 38 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 38 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 38 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 38 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |